USC scientists David Hinton and Mark Humayun discuss their upcoming clinical trial that will use retinal pigment epithelial cells derived from stem cells to replace those lost to macular degeneration, the leading cause of blindness in the elderly in the Western world.
Mentioned in this article: Mark Humayun, MD, PhD